Lokivetmab for Scorpion: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Lokivetmab is the active ingredient in Cytopoint, a prescription injectable biologic used to control itching in dogs with allergic dermatitis or atopic dermatitis. It is a caninized monoclonal antibody that targets interleukin-31 (IL-31), a key itch-signaling protein in dogs. Unlike steroids, it is not a broad anti-inflammatory drug, and unlike many oral allergy medications, it is not processed through typical liver enzyme pathways.

The title of this page mentions scorpion, but that is an important mismatch. Lokivetmab is not labeled or studied for scorpions, and current veterinary references describe it as a dog-only medication. If your scorpion seems ill, itchy, weak, or is behaving abnormally, your vet should evaluate husbandry, temperature, humidity, molt issues, parasites, trauma, and species-specific toxicities rather than trying a dog allergy injection.

For dogs, lokivetmab is usually given as a subcutaneous injection at your vet's clinic. Many dogs improve within 1 to 2 days, and the effect often lasts 4 to 8 weeks, though response length varies by patient.

Lokivetmab is used to reduce itching associated with canine allergic dermatitis and canine atopic dermatitis. In practical terms, your vet may recommend it for dogs that scratch, lick, chew, rub their face, or have recurrent allergy flares linked to environmental triggers.

It is important to know what lokivetmab does not do. It helps block the itch signal, but it does not cure the underlying allergy, and it may not be enough by itself if a dog also has severe skin inflammation, secondary infection, flea allergy, ear disease, or major skin barrier damage. Many dogs still need a broader plan that may include flea control, skin cytology, medicated bathing, diet trials, ear treatment, or infection management.

For a scorpion, there is no established veterinary use for lokivetmab. If a non-dog species is showing skin or behavior changes, your vet will usually focus on species-appropriate diagnostics and supportive care rather than extrapolating from canine allergy medicine.

For dogs, the labeled dose is at least 2 mg/kg by subcutaneous injection. Reference tables commonly describe repeat dosing every 4 to 8 weeks, although some dogs need a shorter interval and others can go longer depending on how quickly itching returns. Your vet chooses the vial combination based on body weight because Cytopoint comes in 10 mg, 20 mg, 30 mg, and 40 mg single-use vials.

This is not a home-use medication for scorpions, and there is no published dosing standard for scorpions in the veterinary sources reviewed. Because lokivetmab is a species-targeted canine antibody, using it in an invertebrate would be outside labeled use and outside evidence-based dosing guidance.

If your dog misses a scheduled injection, your vet will usually advise giving the next dose when signs return or at the next planned visit rather than doubling treatment. If your pet parent household includes multiple species, make sure your vet knows exactly which animal the medication is intended for before any injection is given.

In dogs, reported side effects are usually mild and may include sleepiness, vomiting, diarrhea, decreased appetite, and injection-site discomfort. Some references also note skin redness or ear infections in safety studies. Many dogs tolerate lokivetmab well, but no medication is risk-free.

Rare but serious reactions can happen. See your vet immediately if your dog develops facial swelling, hives, trouble breathing, collapse, or severe vomiting/diarrhea after an injection. Allergic reactions are uncommon, but they matter because lokivetmab is a protein-based injectable medication.

For scorpions, there is no established side-effect profile because this drug is not intended for that species. If a scorpion has weakness, abnormal posture, poor feeding, trouble molting, or sudden death risk factors, your vet should investigate environmental and species-specific causes instead of assuming a dog medication would be safe.

Current veterinary references report no documented drug interactions for lokivetmab in dogs. In safety studies, it was used alongside several common medication groups without obvious added problems, including parasiticides, antibiotics, antifungals, antiemetics, corticosteroids, NSAIDs, antihistamines, allergen immunotherapy, vaccines, and other antipruritic medications.

That said, "no documented interactions" does not mean every combination is automatically right for every patient. Your vet still needs a full medication list, including supplements, topicals, herbal products, and any recent injections. This matters most in dogs with complex allergy disease, active infection, cancer, pregnancy, or multiple chronic illnesses.

For scorpions, there is no interaction data because lokivetmab is not an evidence-based medication for that species. If your scorpion is being treated for mites, dehydration, molt complications, or enclosure-related illness, your vet should build a plan around therapies with species-relevant safety information.